10.65 -0.30 (-2.74%)

57.09% Fall from 52W High

2,786 NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)



Board Meetings - Ortin Global Ltd.

The latest board meeting for Ortin Global Ltd. took place on 12 Feb 2025, for the purpose of Quarterly Results

Ex-date Purpose Notes
12 Feb 2025 Quarterly Results -
13 Nov 2024 Quarterly Results -
13 Aug 2024 Quarterly Results -
31 Jul 2024 Others Inter alia, to consider : 1. Induction of new Directors in the Company. 2. To take note on the resignation of Mrs. Divya Purswani as company secretary & Compliance officer of the company.
30 May 2024 Audited Results -
13 Feb 2024 Quarterly Results -
14 Nov 2023 Quarterly Results -
14 Aug 2023 Quarterly Results -
30 May 2023 Audited Results -
14 Feb 2023 Quarterly Results -
14 Nov 2022 Quarterly Results -
13 Aug 2022 Quarterly Results -
30 May 2022 Audited Results -
14 Feb 2022 Quarterly Results -
13 Nov 2021 Quarterly Results -
14 Aug 2021 Quarterly Results -
09 Jul 2021 Audited Results (Revised)
30 Jun 2021 Audited Results -
13 Feb 2021 Quarterly Results -
23 Jan 2021 Allotment of equity shares Inter alia, to consider and approve allotment of shares to the eligible shareholders as on 13.01.2021 (Record date) pursuant to Scheme of Arrangement.
01 Jan 2021 Others Inter alia, 1.To take on record the sanction of the said Scheme by Hon'ble NCLT Hyderabad Bench and to declare the scheme effective from April 1, 2020.
13 Nov 2020 Quarterly Results -
15 Sep 2020 Quarterly Results -
30 Jul 2020 Audited Results (Revised)
30 Jun 2020 Audited Results -
14 Feb 2020 Quarterly Results -
14 Nov 2019 Quarterly Results -
14 Aug 2019 Quarterly Results -
30 May 2019 Audited Results -
14 Feb 2019 Quarterly Results -
13 Nov 2018 Quarterly Results -
14 Aug 2018 Unaudited Financial Results -
30 May 2018 Audited Results -
13 Feb 2018 Quarterly Results -
14 Dec 2017 Quarterly Results -
14 Sep 2017 Quarterly Results -
31 Aug 2017 To consider Demerger Demerger of Undertaking related to API Intermediates Division (Unit - II) of M/s Ortin Laboratories Limited into M/s Vineet Laboratories Limited by way of demerger procedure.
30 May 2017 Audited Results -
14 Feb 2017 Quarterly Results -
12 Nov 2016 Quarterly Results Limited Review Report for the quarter ended September 30, 2016.
29 Aug 2016 Proposal for Demerger -
12 Aug 2016 Quarterly Results -
30 May 2016 Audited Results -
11 Feb 2016 Quarterly Results & Others 1. Appointment of secretarial auditor for the financial year 2015-16.2. The Board has considered the proposal and decided to start OTC Marketing of Products like Cough Syrup, Pain cream.
14 Nov 2015 Quarterly Results Change of registered office of the Company within the city limits.
14 Aug 2015 Quarterly Results -
30 May 2015 Audited Results -
31 Mar 2015 Appointment of Woman Director & Others 1. Appointment of CFO. 2.Appointment of Secretarial Auditor.
14 Feb 2015 Quarterly Results -
14 Nov 2014 Quarterly Results -
30 May 2014 Audited Results -
14 Feb 2014 Quarterly Results -
14 Nov 2013 Quarterly Results -
14 Aug 2013 Quarterly Results -
30 May 2013 Audited Results -
30 Jan 2013 Quarterly Results -
14 Nov 2012 Quarterly Results -
29 Aug 2012 Quarterly Results (Revised)
12 May 2012 Quarterly Results -
31 Jan 2012 Quarterly Results -
31 Oct 2011 Quarterly Results -
13 Oct 2011 Allotment of Equity Shares To allot the Equity Shares to the shareholders of M/s Vineet Laboratories Pvt Ltd on account of merger of M/s Vineet Laboratories Pvt Ltd with M/s Oritin Laboratories Ltd.
30 Jul 2011 Quarterly Results -
18 Jun 2011 To consider the Merger Progress To consider the followings: 1. The progress in Merger of M/s. Vineet Laboratories Private Ltd. with M/s. Ortin Laboratories Ltd. 2. To acquire stake in M/s. Ortin Biotech Private Ltd.
14 May 2011 Quarterly Results -
31 Jan 2011 Quarterly Results -
28 Dec 2010 Scheme of Merger To consider the followings: 1. Swap Ratio for Amalgamation of Vineet Laboratories Private Limited with Ortin Laboratories Ltd. 2. Scheme of Merger and Amalgamation as said above.
30 Oct 2010 Quarterly Results -
30 Sep 2010 Others 1. To review the performance of the Company. 2. To review the progress made in the Merger of M/s. Vineeth Laboratories Pvt Ltd with the Company M/s Ortin Laboratories Ltd.
26 Aug 2010 Allotment of Equity Shares For allotment of 10,30,000 Equity Shares of Rs. 10 each with a premium of Rs. 8 per Share on conversion of 10,30,000 CW's at an issue price of Rs. 18/- each to the Promoters & Others on pref. basis.
30 Jul 2010 Quarterly Results -
21 Jul 2010 Acquisition of a Co. by way of Merger The Board has decided to acquire Vineet Laboratories Pvt. Ltd. by way of Merger is an unlisted Co. is located in the State of AP & Engaged in Manufacturing of Fine Chemicals, Custom Synthesis & etc.
14 Jun 2010 Allotment of Convertible Warrants The Board has considered and approved the allotment of 15,00,000 Convertible Warrants at an issue price of Rs. 18/- each to the Promoters and Others on preferential basis.
30 Apr 2010 Quarterly Results -
17 Apr 2010 Issue of Equity Share / Warrants To issue of 15,00,000 Convertible Warrants on preferential basis to the Promoters and the others at an issue price of Rs. 18/- per Warrant & to convene EGM on May 18, 2010 for the same.
30 Jan 2010 Quarterly Results -
30 Oct 2009 Quarterly Results -
28 Aug 2009 Audited Results -
31 Jul 2009 Quarterly Results -
30 Apr 2009 Quarterly Results -
31 Jan 2009 Quarterly Results -
30 Oct 2008 Quarterly Results -
25 Jul 2008 Quarterly Results -
29 Jan 2008 Quarterly Results -
09 Jan 2008 To consider Issue of securities inter alia, to consider, the proposal of issue of securities on preferential basis. (Revised)
30 Oct 2007 Quarterly Results -
30 Aug 2007 Audited Results -
30 Jul 2007 Quarterly Results -
30 Apr 2007 Quarterly Results -